Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
Novartis : Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis | MarketScreener
11:32am, Wednesday, 17'th Jun 2020Is IVERIC bio, Inc. (ISEE) Going to Burn These Hedge Funds?
01:39pm, Tuesday, 16'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
Novartis : manufactures and donates 27,000 units of hand sanitizer to New York State | MarketScreener
12:06pm, Tuesday, 16'th Jun 2020
IVERIC bio, Inc. (Nasdaq: ISEE) today announced positive 18 month results from the Company's first Phase 3 clinical trial (OPH2003) for Zimura® (avacincaptad pegol), a novel complement C5 inhibitor,
IVERIC announced that it will report 18 month data from the Zimura® Phase 3 clinical trial in geographic atrophy secondary to AMD on June 15, 2020.
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential
Global Leukemia Therapeutics Market Forecast and Opportunities to 2025 - ResearchAndMarkets.com
12:00am, Thursday, 11'th Jun 2020
The
Correction to Treatments for Macular Degeneration Article on June 8 -- Journal Report | MarketScreener
06:36pm, Wednesday, 10'th Jun 2020Repligen: Management Gambled With 2020 Guidance But Long-Term Growth Story Looks Compelling (NASDAQ:RGEN)
05:04pm, Wednesday, 10'th Jun 2020
Repligen develops and sells bioprocessing technologies and systems involved in the manufacturing of biological drugs. The company operates within a high growth,
IVERIC BIO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | MarketScreener
01:10pm, Wednesday, 10'th Jun 2020Large caps deny they're being outgunned by smaller peers in health R&D - Stockhead
09:18am, Wednesday, 10'th Jun 2020
The journey of each individual medical treatment from idea to market requires the involvement of multiple parties big and small. The general consensus seems to be that it takes a big player to get a d
Somebody tell Mesoblast we get the message
01:31pm, Wednesday, 03'rd Jun 2020
Mesoblast has now put out at least nine announcements since April 9 covering the same potential treatment for COVID-19.
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11:30am, Tuesday, 02'nd Jun 2020
IVERIC bio reported that it granted to two newly hired, non-executive employees non-statutory stock options to purchase 34,000 shares of common stock.
Ophthalmology Devices Market Analysis as per the Latest COVID-19 Impact
09:15am, Tuesday, 02'nd Jun 2020
Jun 02, 2020 (Heraldkeepers) --
New York, June 2, 2020:You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
IVERIC bio to Present at the Jefferies 2020 Healthcare Conference
12:00pm, Wednesday, 27'th May 2020
IVERIC bio announced that Pravin Dugel, MD will present an overview of the Company at the Jefferies 2020 Virtual Healthcare Conference.
